Published in Am J Drug Alcohol Abuse on January 01, 1988
Inhalant use and disorders among adults in the United States. Drug Alcohol Depend (2006) 1.31
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc Natl Acad Sci U S A (1989) 1.01
Nitrite inhalants use and HIV infection among men who have sex with men in China. Biomed Res Int (2014) 0.82
A controlled trial of buprenorphine treatment for opioid dependence. JAMA (1992) 3.55
Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science (1988) 3.01
Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. Am J Public Health (1988) 2.50
The development of a cocaine craving questionnaire. Drug Alcohol Depend (1993) 2.16
Occupational exposure to the human immunodeficiency virus and other blood-borne pathogens. A six-year prospective study. Med J Aust (1993) 1.81
Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch Gen Psychiatry (1990) 1.64
The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J Pharmacol Exp Ther (1967) 1.59
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI). Psychol Rep (1966) 1.48
Methadone--a reevaluation. Arch Gen Psychiatry (1973) 1.44
Safety and side-effects of buprenorphine in the clinical management of heroin addiction. Drug Alcohol Depend (1990) 1.24
Reinforcements from the first drug experience can predict later drug habits and/or addiction: results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine. Drug Alcohol Depend (1983) 1.24
1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science (1969) 1.22
Abrupt withdrawal from therapeutically administered diazepam. Report of a case. Arch Gen Psychiatry (1978) 1.17
Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther (1990) 1.14
Travel and ciguatera fish poisoning. Arch Intern Med (1992) 1.05
Methadone and l-methadyl acetate. Use in management of narcotics addicts. JAMA (1971) 1.04
Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations. J Clin Microbiol (2003) 1.04
The natural history of a heroin epidemic. Am J Public Health (1972) 1.02
Performance, subjective, and physiological effects of nicotine in non-smokers. Drug Alcohol Depend (1993) 0.99
Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI). Psychopharmacologia (1970) 0.99
Missionary health: the great omission. Am J Prev Med (1988) 0.97
HIV infection and international travel. Am Fam Physician (1987) 0.95
Long- and short-term effectiveness of a large-scale proprietary smoking cessation program. -A 4-year follow-up of Smokenders participants. J Clin Psychol (1976) 0.94
Methadyl acetate vs methadone. A double-blind study in heroin users. JAMA (1972) 0.94
Central nervous system supersensitivity to pilocarpine after withdrawal of chronically administered scopolamine. J Pharmacol Exp Ther (1969) 0.94
Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo. J Pharmacol Exp Ther (1986) 0.93
A rapid, quantitative GLC method for the simultaneous determination of nicotine and cotinine. J Anal Toxicol (1983) 0.92
Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings. Arch Gen Psychiatry (1988) 0.92
Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose. Arch Gen Psychiatry (1990) 0.91
Cocaine and heroin use by methadone maintenance patients. NIDA Res Monogr (1989) 0.91
Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation. J Lipid Res (1981) 0.90
Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates. J Nerv Ment Dis (1969) 0.90
Patterns of alcohol, cigarette, and caffeine and other drug use in two drug abusing populations. J Subst Abuse Treat (1993) 0.89
Regeneration of beta-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist. Proc Natl Acad Sci U S A (1982) 0.88
The functioning of individuals on a drug abuse treatment waiting list. Am J Drug Alcohol Abuse (1989) 0.88
The complications of 'ecstasy' (MDMA) JAMA (1988) 0.88
Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res (1989) 0.88
Further experience with methadone in the treatment of narcotics users. Int J Addict (1970) 0.88
Quality of human immunodeficiency virus viral load testing in Australia. J Clin Microbiol (2000) 0.88
Variant Creutzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies. Vox Sang (2001) 0.88
Comparison of acetylmethadol and methadone in the treatment of long-term heroin users. A pilot study. JAMA (1970) 0.88
Increased sensitivity to epinephrine stimulated lipolysis during starvation: tighter coupling of the adenylate cyclase complex. Biochem Biophys Res Commun (1981) 0.87
The heroin copping area. A location for epidemiological study and intervention activity. Arch Gen Psychiatry (1971) 0.87
Children of substance abusers: the life experiences of children of opiate addicts in methadone maintenance. Am J Drug Alcohol Abuse (1994) 0.86
Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse (1995) 0.86
Cocaine-induced locomotor activity in rats. Pharmacol Biochem Behav (1991) 0.86
Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse (1991) 0.86
Initial identification and characterization of sigma receptors on human peripheral blood leukocytes. J Pharmacol Exp Ther (1988) 0.86
Intravenous cocaine infusions in humans: dose responsivity and correlations of cardiovascular vs. subjective effects. Pharmacol Biochem Behav (1989) 0.86
Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers. Clin Pharmacol Ther (1988) 0.85
A central hypothermic response to pilocarpine in the mouse. J Pharmacol Exp Ther (1969) 0.84
Adrenergic ligand liposolubility in membranes. Direct assessment in a beta-adrenergic binding system. Mol Pharmacol (1982) 0.84
Abuse potential of loperamide. Clin Pharmacol Ther (1980) 0.84
The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987. Arch Intern Med (1990) 0.84
Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers. Biol Psychiatry (1989) 0.84
Opiate withdrawal as measured by the Addiction Research Center Inventory (ARCI). Dis Nerv Syst (1968) 0.83
Impaired memory for treatment-relevant information in inpatient men alcoholics. J Stud Alcohol (1984) 0.83
Multisite evaluation of four anti-HIV-1/HIV-2 enzyme immunoassays. Australian HIV Test Evaluation Group. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.83
Assessment of nalmefene glucuronide as a selective gut opioid antagonist. Drug Alcohol Depend (1995) 0.83
The rapid development of physical dependence on barbiturates. J Pharmacol Exp Ther (1965) 0.83
Response of medical personnel to an on-site smoking cessation program. J Clin Psychol (1976) 0.83
Amyl nitrite alters human in vitro immune function. Immunopharmacol Immunotoxicol (1991) 0.82
Adipocyte hormone responsiveness and aging in the rat: problems in the interpretation of aging research. J Am Geriatr Soc (1984) 0.82
EEG and brainstem auditory evoked response potentials in adult male drug abusers with self-reported histories of aggressive behavior. Biol Psychiatry (1989) 0.82
Neonatal capsaicin modifies morphine withdrawal signs in the rat. Neurosci Lett (1986) 0.82
Subjective experiences produced by the withdrawal of opiates. Br J Addict Alcohol Other Drugs (1970) 0.82
Tobacco use as a mental disorder: the rediscovery of a medical problem. NIDA Res Monogr (1977) 0.81
Extraction techniques for narcotics, barbiturates, and central nervous system stimulants in a drug abuse urine screening program. J Chromatogr (1971) 0.81
Impulsiveness and subjective effects of intravenous cocaine administration in the laboratory. J Subst Abuse (1994) 0.81
Beta adrenergic regulation of rat liver glycogenolysis during aging. Exp Gerontol (1993) 0.81
Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal. Clin Pharmacol Ther (1983) 0.81
Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat. Neuroreport (1990) 0.81
XVII. Pharmacological denervation supersensitivity in the central nervous system: a theory of physical dependence. Res Publ Assoc Res Nerv Ment Dis (1968) 0.81
Beta-adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging. Endocrinology (1987) 0.81
Addiction Research Center Inventory (ARCI): development of a general drug estimation scale. J Nerv Ment Dis (1965) 0.81
Low nicotine cigarettes: cigarette consumption and breath carbon monoxide after one year. Clin Pharmacol Ther (1983) 0.81
Racial differences in sexual behaviors related to AIDS in a nineteen-city sample of street-recruited drug injectors. NADR Consortium. AIDS Educ Prev (1993) 0.81
Tricyclic antidepressants in the treatment of depression associated with alcoholism. J Clin Psychopharmacol (1981) 0.81
Dexamethasone suppression test in recently detoxified alcoholics: clinical implications. J Clin Psychopharmacol (1984) 0.81
Kids and cocaine--a treatment dilemma. J Subst Abuse Treat (1989) 0.80
Loss of rat ventricular alpha 1-adrenergic receptors during aging. Life Sci (1982) 0.80
HTLV-I associated myelopathy in a Seychellois immigrant. Med J Aust (1993) 0.80
A single diagram for computation of tetrachoric correlations. J Gen Psychol (1967) 0.80
Plasma relaxin immunoactivity in the pig at parturition and during nuzzling and suckling. J Reprod Fertil (1979) 0.80
The social structure of a heroin copping community. Am J Psychiatry (1971) 0.80
Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan. Pharmacol Biochem Behav (1991) 0.80
Quantitation of beta adrenergic receptors in rat liver: confounding effect of displaceable but nonstereospecific antagonist binding. J Recept Res (1981) 0.80
Progress report of the NIDA Addiction Research Center, Baltimore, Maryland, 1982. NIDA Res Monogr (1983) 0.80
Cigarette smoking as an addiction. Am Lung Assoc Bull (1976) 0.80
A comparison of the performance of nine commercially available anti-HTLV-I screening assays. J Virol Methods (1993) 0.79
Are missionaries at risk for AIDS? Evaluation for HIV antibodies in 3,207 protestant missionaries. South Med J (1989) 0.79